Skip to main content
Board of Directors
Innovation engine overview
Extracting microbial biodiversity
Screening for new activity
Active compound characterization
Technology platform overview
DEINOVE is pioneering the exploration of “microbial dark matter”
By revealing the metabolic potential of rare bacteria or still classified as uncultivable, the company tackles a global health and economic challenge:
DEINOVE- Third convening to an Extraordinary General Meeting on July 5, 2022
DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company, pioneer in the exploration and...
DEINOVE - Adoption of all the ordinary resolutions at the Shareholders’ Meeting of May 30, 2022
The Extraordinary Shareholders’ Meeting will be convened on third notice on July 5, 2022 DEINOVE (...
More press releases